The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

Developing a robust approach to mitigating the current opioid crisis in the USA will require translating novel evidence-based, neuroscience-informed treatments into clinical care and public policy.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications.

THE Turkish prime ministerial adviser who was photographed last week kicking a mourner of the Soma mine disaster has gone off sick with pain in his right leg. Yusuf Yerkel was signed off for a week ...

Jesse Eisenberg directed movies Eisenberg has begun to take on more directing projects. As we mentioned above, A Real Pain is the second movie he has directed, preceded by When You Finishing Saving ...

Speaking on a panel at the World Economic Forum in Davos, Hassabis, who also runs DeepMind drug-discovery spin-off Isomorphic Labs, said he expected to have "some AI-designed drugs in clinical trials ...

A judge in Texas ruled Thursday that three other states can move ahead with their effort to roll back federal rules and make it harder for people across the U.S. to access the abortion drug ...